# Boric Acid Diminishes Sciatic Nerve Injury-Induced Apoptosis, Oxidative Stress, and Pain via The Block of TRPV1 Channel in Mice

**Authors:** Kemal Ertilav, Mustafa Nazıroğlu

PMC · DOI: 10.1007/s12011-025-04698-8 · Biological Trace Element Research · 2025-06-28

## TL;DR

Boric acid reduces pain, cell death, and oxidative stress in mice with sciatic nerve injury by blocking a specific channel called TRPV1.

## Contribution

This study is the first to show that boric acid alleviates sciatic nerve injury effects via TRPV1 inhibition.

## Key findings

- Boric acid reduced pain intensity and TRPV1-related calcium entry in sciatic nerve-injured mice.
- Boric acid treatment improved mitochondrial function and reduced oxidative stress and apoptosis in injured mice.
- Boric acid's effects were comparable to a known TRPV1 antagonist in reducing injury-induced damage.

## Abstract

The main actors of sciatic nerve injury (SNI) are pain, apoptosis, excessive reactive oxygen species (ROS), and Ca2+ entry. However, the role of antioxidant and antiapoptotic boric acid (BoA) through TRPV1 inhibition on the actors in SNI-induced mice has not yet been elucidated. We investigated whether BoA protected the SNI actors in mice undergoing SNI. The thirty-two mice were divided into four groups: Control, BoA, SNI, and SNI + BoA. For four weeks following SNI induction, the BoA and SNI + BoA received 100 mg/kg BoA intraperitoneally. The SNI group, but not the BoA or BoA + SNI groups, indicated increases in TRPV1 current density and Ca2+ concentration induced by the TRPV1 agonist (capsaicin). The SNI + BoA group had a reduction in the increases of pain intensity (threshold of paw withdrawal and delay of thermal paw withdrawal) induced by SNI. In the brain, blood, and sciatic nerve of the SNI group, BoA and TRPV1 antagonist (capsazepine) treatments reduced the increases of mitochondrial membrane dysfunction, apoptosis, caspases (-3, -8, and -9), lipid peroxidation, mitochondrial, and intracellular ROS caused by SNI through upregulation of cell viability and antioxidants (vitamin A, vitamin E, β-carotene, glutathione, and glutathione peroxidase). In conclusion, BoA therapy reduced the rise in mitochondrial ROS, apoptosis, and Ca2+ entry in the sciatic nerve via inhibiting TRPV1. Therefore, the BoA may be a useful novel treatment through modulation of TRPV1 for oxidative stress, apoptosis, and pain produced by SNI.

## Linked entities

- **Proteins:** TRPV1 (transient receptor potential cation channel subfamily V member 1)
- **Chemicals:** boric acid (PubChem CID 7628), capsaicin (PubChem CID 1548943), capsazepine (PubChem CID 2733484), vitamin A (PubChem CID 445354), vitamin E (PubChem CID 14985), β-carotene (PubChem CID 573), glutathione (PubChem CID 124886)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Trpv1 (transient receptor potential cation channel, subfamily V, member 1) [NCBI Gene 193034] {aka OTRPC1, TRPV1alpha, TRPV1beta, VR-1, Vr1}
- **Diseases:** mitochondrial membrane dysfunction (MESH:D028361), Pain (MESH:D010146), SNI (MESH:D020426)
- **Chemicals:** Ca (MESH:D002118), vitamin E (MESH:D014810), ROS (MESH:D017382), β-carotene (MESH:D019207), lipid (MESH:D008055), BoA (MESH:C032688), glutathione (MESH:D005978), capsazepine (MESH:C071423), vitamin A (MESH:D014801)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12847084/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12847084/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12847084/full.md

---
Source: https://tomesphere.com/paper/PMC12847084